Human CD127 ELISA Kit (ab270880)
Key features and details
- One-wash 90 minute protocol
- Sensitivity: 15.23 pg/ml
- Range: 46.88 pg/ml - 3000 pg/ml
- Sample type: Cell culture media, Cit plasma, EDTA Plasma, Hep Plasma, Serum
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Human
Overview
-
Product name
Human CD127 ELISA Kit
See all CD127 kits -
Detection method
Colorimetric -
Precision
Intra-assay Sample n Mean SD CV% Serum 8 4.4% Inter-assay Sample n Mean SD CV% Serum 3 4.4% -
Sample type
Serum, Cell culture media, Hep Plasma, EDTA Plasma, Cit plasma -
Assay type
Sandwich (quantitative) -
Sensitivity
15.23 pg/ml -
Range
46.88 pg/ml - 3000 pg/ml -
Recovery
Sample specific recovery Sample type Average % Range Serum 98 95% - 100% Cell culture media 93 89% - 97% Hep Plasma 92 87% - 97% EDTA Plasma 93 91% - 97% Cit plasma 98 93% - 105% -
Assay time
1h 30m -
Assay duration
One step assay -
Species reactivity
Reacts with: Human -
Product overview
Human CD127 ELISA kit (ab270880) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of CD127 protein in human serum, plasma and cell and tissue supernatant sampls. It uses our proprietary SimpleStep ELISA® technology. Quantitate human CD127 with 15.23 pg/mL sensitivity.
SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:
-Single-wash protocol reduces assay time to 90 minutes or less
-High sensitivity, specificity and reproducibility from superior antibodies
-Fully validated in biological samples
-96-wells plate breakable into 12 x 8 wells stripsA 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpeStep ELISA® kits.
-
Notes
CD127 is a component of the IL-7R heterodimer. CD127 is found on a variety of cells, including naïve and memory T cells, and is a receptor for IL-7 and TSLP. Mutations in CD127 have been linked to an increased susceptibility to multiple sclerosis, rheumatic arthritis, and T-cell acute lymphoblastic leukemia.
-
Platform
Pre-coated microplate (12 x 8 well strips)
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 1 x 96 tests 10X Human CD127 Capture Antibody 1 x 600µl 10X Human CD127 Detector Antibody 1 x 600µl 10X Wash Buffer PT (ab206977) 1 x 20ml Antibody Diluent 4BI 1 x 6ml Human CD127 Lyophilized Recombinant Protein 2 vials Plate Seals 1 unit Sample Diluent NS (ab193972) 1 x 12ml SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit Stop Solution 1 x 12ml TMB Development Solution 1 x 12ml -
Research areas
-
Function
Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP). -
Involvement in disease
Defects in IL7R are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in IL7R are a cause of susceptibility to multiple sclerosis type 3 (MS3) [MIM:612595]. A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheat, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. Note=A polymorphism at position 244 strongly influences susceptibility to multiple sclerosis. Overtransmission of the major 'C' allele coding for Thr-244 is detected in offspring affected with multiple sclerosis. In vitro analysis of transcripts from minigenes containing either 'C' allele (Thr-244) or 'T' allele (Ile-244) shows that the 'C' allele results in an approximately two-fold increase in the skipping of exon 6, leading to increased production of a soluble form of IL7R. Thus, the multiple sclerosis associated 'C' risk allele of IL7R would probably decrease membrane-bound expression of IL7R. As this risk allele is common in the general population, some additional triggers are probably required for the development and progression of MS. -
Sequence similarities
Belongs to the type I cytokine receptor family. Type 4 subfamily.
Contains 1 fibronectin type-III domain. -
Domain
The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.
The box 1 motif is required for JAK interaction and/or activation. -
Post-translational
modificationsN-glycosylated IL-7Ralpha binds IL7 300-fold more tightly than the unglycosylated form. -
Cellular localization
Secreted and Cell membrane. - Information by UniProt
-
Alternative names
- CD 127
- CD127
- CD127 antigen
see all -
Database links
- Entrez Gene: 3575 Human
- Omim: 146661 Human
- SwissProt: P16871 Human
- Unigene: 591742 Human
- Unigene: 635723 Human
Images
-
SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.
-
The CD127 standard curve was prepared as described in Section 10. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed. The CD127 standard curve was prepared as described in Section 10. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.
-
The concentrations of CD127 were measured in duplicates, interpolated from the CD127 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 20%, plasma (citrate) 50%, plasma (heparin) 25%, and plasma (EDTA) 25%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean CD127 concentration was determined to be 7.89 ng/mL in serum, 5.56 ng/mL in plasma (citrate), 7.56 ng/ml in plasma (heparin), and 12.55 ng/mL in plasma (EDTA).
-
Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean CD127 concentration was determined to be 7.09 ng/mL with a range of 3.69 – 11.63 ng/mL.
-
To learn more about the advantages of recombinant antibodies see here.